Federal
U.S. Department of Health and Human Services (DHHS) - Health Resources and Services Administration (HRSA)
05/12/22
06/21/22 11:59 PM ET
Cooperative agreement to a USA nonprofit organization, government agency, IHE, tribe, nonprofit hospital, or outpatient clinic to improve treatment for BIPOC individuals diagnosed with HIV. Applicants are advised that required registrations may take as long as one month to complete. The successful applicant will provide technical assistance, capacity development, and evaluation to support ten demonstration sites in the development and pilot implementation of protocols for a novel long-acting injectable antiretroviral HIV treatment.
Increasing Uptake of Long-Acting Injectable Antiretrovirals Among People with HIV
The purpose of this program is to develop, implement, and evaluate protocols for successful use of long-acting injectable (LAI) antiretroviral (ARV) medication within clinical practice.
Increasing viral suppression and client retention in care are critical components of meeting the goals of the National HIV/AIDS Strategy (2022-2025) and ending the HIV epidemic. In order to reach these goals, it is imperative for HIV care communities to address health care inequities. With the advent of FDA-approved long-acting injectable (LAI) antiretroviral (ARV) medication formulations, initiatives that promote, facilitate, and evaluate the uptake and ongoing utilization of LAI ARV medication may improve clinical outcomes for people with HIV, especially for minority populations who continue to face disparate health care inequities and stigma. This project is designed to develop protocols, implement them and modify as needed, to increase uptake of LAI ARV medications among people of color with HIV, since LAI ARV medications may offer benefits in addressing health inequities and achieving viral suppression.
In addition to alleviating challenges associated with oral medications, ongoing utilization of LAI ARV medications in lieu of oral regimens may potentially reduce HIV-related stigma and enhance protection of health privacy. While there are some unique clinical and social benefits to this injectable drug formulation, some aspects of its distribution, administration requirements, and billing have already hindered uptake and utilization within the Ryan White HIV/AIDS Program (RWHAP). As minority populations have historically experienced significant disparities in accessing care and treatment, including the health literacy and access to health care coverage options necessary to engage in care, developing interventions to increase the uptake of LAI ARV medication formulations will help to proactively address and potentially reduce or prevent disparities minority communities may face in accessing this breakthrough therapy.
This cooperative agreement will fund one (1) organization that will serve as the Coordination and Evaluation Provider (CEP) to support ten (10) demonstration sites in the development and pilot implementation of protocols for a novel LAI ARV HIV treatment. The CEP must have the capacity and infrastructure to support development, implementation, and refinement of LAI ARV medication administration protocols with the goal of replicating and expanding successful protocols.
As of the release date of this NOFO, the current LAI ARV medication is now approved for injection every 2 months, requiring appointment attendance for injection at least 6 times per year versus the typical 4 or less annual visits for patients on daily oral regimens. The importance of increasing the uptake of this injectable is to eliminate the need for daily medication adherence and has significant implications for reducing stigma for patients currently taking oral HIV medications.
For program resources and models, see https://www.grantwatch.com/downloads/13592956_202893_HAB_HRSA-22-155_U1S_MHAF_LAI_Final.pdf#page=10.
For program involvement and expectations, and for recipient's responsibilities, see https://www.grantwatch.com/downloads/13592956_202893_HAB_HRSA-22-155_U1S_MHAF_LAI_Final.pdf#page=12.
GrantWatch ID#: 202893
$1,500,000
1
Estimated Annual Award Amount:
- $1,500,000 in year 1 (FY 2022)
- $2,000,000 in year 2
- $2,000,000 in year 3
- $1,500,000 in year 4
Period of Performance: September 1, 2022 through August 31, 2026 (4 years)
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
For information and/or technical assistance regarding business, administrative, or fiscal issues, please contact:
Beverly Helene Smith
Grants Management Specialist
Division of Grants Management Operations, OFAM
Health Resources and Services Administration
5600 Fishers Lane, Mailstop 10SWH03
Rockville, MD 20857
Telephone: (301)443-7065
Email: bsmith@hrsa.gov
For information regarding the overall program issues and/or technical assistance, contact:
Susan Robilotto, D.O., Director, Division of State HIV/AIDS Programs
Attn: Increasing Uptake of Long-Acting Injectable Antiretrovirals Among People
with HIV
HIV/AIDS Bureau
Health Resources and Services Administration
5600 Fishers Lane, Room 09W52
Rockville, MD 20857
Telephone: (301) 443-6554
Email: srobilotto@hrsa.gov
For technical assistance with submitting the application in Grants.gov, contact:
Grants.gov Contact Center
Telephone: 1-800-518-4726 (International callers dial 606-545-5035)
Email: support@grants.gov
Self-Service Knowledge Base
For assistance when working online to submit information and reports electronically, contact:
HRSA Contact Center
Telephone: (877) 464-4772 / (877) Go4-HRSA
TTY: (877) 897-9910
93.899
USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming
Grants to USA and territories government agencies, educational institutions, nonprofit organizations, faith-based and community organizations, and tribal governments for activities to reduce violent crime in local communities. Applicants are advised that required regist
Grants to Colorado school districts to address attendance and truancy-related issues among students. Funding is intended to reduce the incidence of suspension and expulsion. Eligible uses of funding include program development costs, salaries, and benefits, as well as t
Grants to Massachusetts nonprofit organizations for programs and projects that benefit local communities. Applicants must submit a letter of intent prior to submitting a full proposal. Priority funding is intended to address the needs of low-income youth, children, and
Grants of up to $50,000 to researchers affiliated with qualified USA institutions to advance research in the field of pediatric oncology. Applicants must submit a letter of intent prior to submitting a full application. Funding is intended to increase the institution's
Grants to USA and Canada nonprofit charitable organizations to impact public policy in a variety of national and international issues. In previous years, grants have been awarded for general operations and project support to think tanks, national councils, judicial orga
Grants to New York and Pennsylvania families living in eligible areas and caring for a child with cancer to offset expenses related to the child's cancer treatments. Funding is intended to cover costs not covered by health insurance, including travel costs, housing, and
Grants to USA nonprofit organizations for the preservation of seascapes and landscapes through coral conservation and responsible mining projects. Applicants must submit a Letter of Intent in order to apply. Funding is intended for reclamation, restoration, research, ed
Grants to Indiana nonprofit organizations in eligible locations for projects and capital campaigns that address community needs. Applicants requesting support for a capital campaign are asked to contact the funding source prior to submitting an application. Projects are
Awards to Kentucky individuals, organizations, businesses, agencies, and schools to recognize significant contributions to the arts within the state or nationally. The awards are intended to honor outstanding recipients in nine award categories. Awardees have supported
Grants of up to $2,500 to Indiana government agencies, nonprofit organizations, and public schools in eligible regions for educational projects. Funding is intended for youth-serving organizations. Focus areas include arts and culture, education, environment, community
13592956_202893_HAB_HRSA-22-155_U1S_MHAF_LAI_Final.pdf